Heidelberg Pharma AG

Management Reports • Jul 12, 2007

News Details

Ad-hoc | 12 July 2007 08:29

WILEX AG:

WILEX AG / Forecast

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

WILEX AG - improved financial outlook due to cost optimization

Munich, 12 July 2007. The Munich-based biopharmaceutical company WILEX AG
(ISIN DE0006614720/Frankfurt Stock Exchange/Prime Standard) revises its
financial guidance for 2007 due to optimization of the programme for
production of RENCAREX® consistency lots and due to higher than anticipated
patient randomisation in countries with lower costs. The Company
expects to reduce expenses in the financial year 2007 by approximately 12 %
below the original budget. Assuming a planned project progress and without
additional cash inflow the available liquidity of WILEX will probably reach
until the first quarter of 2009 which is beyond the previously published
forecast of the second half of 2008.

This communication contains certain forward-looking statements, relating to
the Company’s business, which can be identified by the use of
forward-looking terminology such as 'estimates', 'believes', 'expects',
'may', 'will' 'should' 'future', 'potential' or similar expressions or by
general discussion of strategy, plans or intentions of the Company. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors, which may cause our actual results of operations,
financial condition, performance, or achievements, or industry results, to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, prospective investors and partners are cautioned not
to place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such forward-looking statements to reflect future
events or developments.
Given these uncertainties, prospective investors and partners are cautioned
not to place undue reliance on such forward-looking statements. We disclaim
any obligation to update any such forward-looking statements to reflect
future events or developments.
DGAP 12.07.2007

---

Language: English
Issuer: WILEX AG
Grillparzerstr. 10
81675 München Deutschland
Phone: +49 (0)89 41 31 38 - 0
Fax: +49 (0)89 41 31 38 - 99
E-mail: info@wilex.com
Internet: www.wilex.com
ISIN: DE0006614720
WKN: 661472
Indices:
Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in
Berlin-Bremen, Düsseldorf, München, Stuttgart

End of News DGAP News-Service

---